{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:48:43Z","timestamp":1740181723057,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Children with ventricular septal defect (VSD) and large systemic-to-pulmonary shunts eventually develop pulmonary hypertension (PH). The perioperative management of patients with VSD and PH is quite troublesome and still debatable, especially in developing countries where the different management options and standardization of treatment is not available. Oral phosphodiesterase type 5 (PDE-5) inhibitors are good treatment options being widely available, cheap, easy administration and do not require extensive monitoring. The aim of our study was to evaluate the effect of the PDE-5 inhibitors when given orally, early preoperative and continued for 3\u00a0months postoperative on controlling postoperative PH with its effect on right ventricle (RV) functions. Fifty-one patients were randomly assigned to either sildenafil or tadalafil, 1\u00a0week before and continued for 3\u00a0months after corrective surgery. The control group received a placebo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was no significant difference in the improvement in the right ventricle systolic pressure (RVSP) between both groups, early in the postoperative period (<jats:italic>P<\/jats:italic>\u2009=\u20090.255) and in follow-up (<jats:italic>P<\/jats:italic>\u2009=\u20090.259). There was also no significant difference in the changes in mean pulmonary artery pressure (mPAP), postoperatively and on follow-up (<jats:italic>P<\/jats:italic>\u2009=\u20090.788 and 0.059, respectively). There was a drop in RV functions in both groups postoperatively which improved on follow-up; however, it was not significant between both groups. The length of intensive care unit (ICU) stay was similar between both groups (<jats:italic>P<\/jats:italic>\u2009=\u20090.143).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Perioperative administration of PDE-5 inhibitors does not have an impact on the clinical course as regards improvement in pulmonary artery (PA) pressure, ventricular functions and ICU stay.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43044-024-00475-5","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T10:02:09Z","timestamp":1716285729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of phosphodiesterase type 5 inhibitors on surgical outcome of ventricular septal defect and pulmonary hypertension patients"],"prefix":"10.1186","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1227-344X","authenticated-orcid":false,"given":"Khaled Ahmed","family":"Shams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia Monir","family":"Ellahony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7717-1412","authenticated-orcid":false,"given":"Ahmed Fouad","family":"Halima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1145-1141","authenticated-orcid":false,"given":"Rania Salah","family":"Elzayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"issue":"9771","key":"475_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(10)61339-6","volume":"377","author":"DJ Penny","year":"2011","unstructured":"Penny DJ, Vick GW (2011) Ventricular septal defect. Lancet 377(9771):1103\u20131112. https:\/\/doi.org\/10.1016\/S0140-6736(10)61339-6","journal-title":"Lancet"},{"key":"475_CR2","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/S0022-5223(96)70019-3","volume":"112","author":"K Bando","year":"1996","unstructured":"Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K (1996) Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. J Thorac Cardiovasc Surg 112:1600\u20131609","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2022","key":"475_CR3","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM et al (2022) ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Eur Heart J 43(2022):3619\u20133731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237","journal-title":"Eur Heart J"},{"key":"475_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0022-5223(19)33382-3","volume":"48","author":"GL Hallman","year":"1964","unstructured":"Hallman GL, Cooley DA, Wolfe RR, McNamara DG (1964) Surgical treatment of ventricular septal defect associated with pulmonary hypertension. J Thorac Cardiovasc Surg 48:588\u2013600","journal-title":"J Thorac Cardiovasc Surg"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1067\/mtc.2001.113747","volume":"121","author":"I Schulze-Neick","year":"2001","unstructured":"Schulze-Neick I, Li J, Penny DJ, Redington AN (2001) Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. J Thorac Cardiovasc Surg 121:1033\u20131039","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6 Suppl","key":"475_CR6","doi-asserted-by":"publisher","first-page":"52S","DOI":"10.1378\/chest.09-2861","volume":"137","author":"I Adatia","year":"2010","unstructured":"Adatia I, Kothari SS, Feinstein JA (2010) Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl):52S-61S","journal-title":"Chest"},{"key":"475_CR7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1067\/mtc.2002.121497","volume":"123","author":"L Lindberg","year":"2002","unstructured":"Lindberg L, Olsson AK, J\u00f6gi P, Jonmarker C (2002) How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg 123:1155\u20131163","journal-title":"J Thorac Cardiovasc Surg"},{"key":"475_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4172\/2155-9880.1000392","volume":"6","author":"A Hofer","year":"2015","unstructured":"Hofer A, Heschl M, Kern C et al (2015) A prospective randomised study of postoperative prophylactic application of sildenafil after pediatric cardiac surgery. J Clin Exp Cardiolog 6:8. https:\/\/doi.org\/10.4172\/2155-9880.1000392","journal-title":"J Clin Exp Cardiolog"},{"key":"475_CR9","first-page":"1519","volume-title":"Moss and Adams\u2019 heart disease in infants, children, and adolescents including the fetus and young adult","author":"DD Ivy","year":"2016","unstructured":"Ivy DD (2016) Pediatric pulmonary hypertension. In: Allen HD, Shaddy RE, Penny DJ, Feltes TF, Cetta F (eds) Moss and Adams\u2019 heart disease in infants, children, and adolescents including the fetus and young adult. Wolters Kluwer, Philadelphia, pp 1519\u20131558"},{"key":"475_CR10","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1161\/CIRCULATIONAHA.104.473371","volume":"111","author":"T Humpl","year":"2005","unstructured":"Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I (2005) Beneficial effect of oral sildenafil therapy childhood pulmonary arterial hypertension: twelvemonth clinical trial of a single-drug, open label, pilot study. Circulation 111:3274\u20133280","journal-title":"Circulation"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/icvts\/ivt353","volume":"17","author":"AAH El Midany","year":"2013","unstructured":"El Midany AAH, Mostafa EA, Azab S et al (2013) Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure. Interact Cardiovasc Thorac Surg 17:963\u2013968. https:\/\/doi.org\/10.1093\/icvts\/ivt353","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"12","key":"475_CR12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 18(12):1440\u20131463","journal-title":"J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"key":"475_CR13","first-page":"323","volume":"43","author":"SC Mitchell","year":"1971","unstructured":"Mitchell SC, Korones SB, Berendes HW (1971) Congenital heart disease in 56,109 births. Incid Nat Hist Circ. 43:323\u2013332","journal-title":"Incid Nat Hist Circ."},{"key":"475_CR14","first-page":"298","volume-title":"Pediatric cardiac surgery","author":"C Mavroudis","year":"2003","unstructured":"Mavroudis C, Backer CL, Jacobs JP (2003) Ventricular septal defect. In: Mavroudis C, Backer CL (eds) Pediatric cardiac surgery, 3rd edn. Mosby, Philadelphia, pp 298\u2013320","edition":"3"},{"key":"475_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1620\/tjem.156.39","volume":"156","author":"K Haneda","year":"1988","unstructured":"Haneda K, Ishizawa E, Yamaki S et al (1988) Surgical closure of ventricular septal defect in the first year of life: forty-three consecutive successful cases. Tohoku J Exp Med 156:39\u201345","journal-title":"Tohoku J Exp Med"},{"key":"475_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1620\/tjem.174.41","volume":"174","author":"K Haneda","year":"1994","unstructured":"Haneda K, Sato N, Togo T, Miura M, Hata M, Mohri H (1994) Late results after correction of ventricular septal defect with severe pulmonary hypertension. Tohoku J Exp Med 174:41\u201348","journal-title":"Tohoku J Exp Med"},{"key":"475_CR17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1365-2044.2011.06702.x","volume":"66","author":"A Vassalos","year":"2011","unstructured":"Vassalos A, Peng E, Young D et al (2011) Preoperative sildenafil and pulmonary endothelial-related complications following cardiopulmonary bypass: a randomized trial in children undergoing cardiac surgery. Anaesthesia 66:472\u2013480","journal-title":"Anaesthesia"},{"key":"475_CR18","first-page":"238","volume":"38","author":"G Palma","year":"2011","unstructured":"Palma G, Giordano R, Russolillo V et al (2011) Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery. Tex Heart Inst J 38:238\u2013242","journal-title":"Tex Heart Inst J"},{"issue":"3","key":"475_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.15171\/jcvtr.2017.31","volume":"9","author":"H Bigdelian","year":"2017","unstructured":"Bigdelian H, Sedighi M (2017) The role of preoperative sildenafil therapy in controlling of postoperative pulmonary hypertension in children with ventricular septal defects. J Cardiovasc Thorac Res 9(3):179\u2013182. https:\/\/doi.org\/10.15171\/jcvtr.2017.31","journal-title":"J Cardiovasc Thorac Res"},{"issue":"3","key":"475_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/ejca.ejca_6_21","volume":"15","author":"S Kesvani","year":"2021","unstructured":"Kesvani S, Sachan P, Champaneri B et al (2021) Intravenous sildenafil for perioperative management of patients with pulmonary artery hypertension in congenital heart surgery\u2014a prospective randomized study. Egypt J Cardiothorac Anesth 15(3):84\u201391. https:\/\/doi.org\/10.4103\/ejca.ejca_6_21","journal-title":"Egypt J Cardiothorac Anesth"},{"issue":"4","key":"475_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.4103\/0971-9784.166457","volume":"18","author":"V Sharma","year":"2015","unstructured":"Sharma V, Joshi S, Joshi A, Kumar G, Arora H, Garg A (2015) Does intravenous sildenafil clinically ameliorate pulmonary hypertension during perioperative management of congenital heart diseases in children?\u2014A prospective randomized study. Ann Card Anaesth 18(4):510\u2013516","journal-title":"Ann Card Anaesth"},{"issue":"9","key":"475_CR22","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1017\/S1047951117000981","volume":"27","author":"MR Sabri","year":"2017","unstructured":"Sabri MR, Bigdelian H, Hosseinzadeh M, Ahmadi A, Ghaderian M, Shoja M (2017) Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts. Cardiol Young. 27(9):1686\u20131693. https:\/\/doi.org\/10.1017\/S1047951117000981","journal-title":"Cardiol Young."},{"key":"475_CR23","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1161\/CIRCULATIONAHA.105.540500","volume":"112","author":"B Borlaug","year":"2005","unstructured":"Borlaug B, Melenovsky V, Marhin T, Fitzgerald P, Kass D (2005) Sildenafil inhibits \u03b2-adrenergic-stimulated cardiac contractility in humans. Circulation 112:2642\u20132649","journal-title":"Circulation"},{"key":"475_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/01.RES.0000152262.22968.72","volume":"96","author":"E Takimoto","year":"2005","unstructured":"Takimoto E, Champion H, Belardi D et al (2005) cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS-3 dependent mechanism. Circ Res 96:100\u2013109","journal-title":"Circ Res"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-024-00475-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-024-00475-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-024-00475-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T10:09:28Z","timestamp":1716286168000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-024-00475-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1186\/s43044-024-00475-5","relation":{},"ISSN":["2090-911X"],"issn-type":[{"type":"electronic","value":"2090-911X"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the ethical committee of faculty of Medicine, Menoufia University (IRB approval number: 10\/2022 PDEI 11-2), and an informed parental consent was obtained for each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}